Sheel Biotech Limited
Sheel Biotech Limited (SHEEL): company summary
The company's revenue grew 2.2% annually over three years but rose 100.0% in the latest quarter compared to the same quarter a year earlier.
Sheel Biotech Limited (SHEEL) is a micro-cap Services company valued at ₹127 crore operating in Diversified Commercial Services on the NSE and BSE.
- Recent price move
- Sheel Biotech Limited last traded at ₹62.5, unchanged on the day.
- Recent developments
- On 2025-09-30, the company reported a net profit of ₹0 crore for the latest quarter, marking a swing from a net loss of ₹4 crore in the same quarter a year earlier. This indicates a significant improvement in profitability for the quarter.
- Financial performance
- The company's revenue grew 2.2% annually over three years but rose 100.0% in the latest quarter compared to the same quarter a year earlier. Net profit increased 5.5% annually over three years and swung from a net loss of ₹4 crore to a profit of ₹0 crore in the latest quarter, though the annual net profit margin remained at 10.7%.
- Valuation multiples
- The stock trades at 10.8 times earnings, a discount to the Services median of 16.3, 0.99 times book value.
- Things to watch
- The company's latest quarter net profit was ₹0 crore, which is flat compared to the previous year's quarter. The stock is 37.0% below its 52-week high, and the company's market cap is ₹123 crore, classifying it as a micro-cap stock.
- Where it stands
- The company's latest quarter revenue rose 100.0% compared to the same quarter a year earlier, while net profit was ₹0 crore. The stock is 37.0% below its 52-week high, and the company remains a micro-cap stock with a market cap of ₹123 crore.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by valuation (8.1) and risk (7.2), but weakest on quality (4.0).
DocStoX score
Low confidenceAt a glance
Key highlights
- Low leverage — D/E 0.07
- Profitable in all of the last 4 years
- Undemanding at 11× earnings
- Small ₹127 cr company — thinner liquidity
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Services stocks · Diversified Commercial Services
Explore Sheel Biotech Limited’s valuation
Free deep-dive tools · no sign-up
Sheel Biotech Limited peers in Services
Other Services stocks on the NSE & BSE. See the full Services sector list.
Compare Sheel Biotech Limited with peers
Related tools & concepts
Value Sheel Biotech Limited with the ratios and calculators DocStoX uses in its analysis.

